Advertisement
U.S. markets closed

CSPC Pharmaceutical Group Limited (1093.HK)

HKSE - HKSE Delayed Price. Currency in HKD
5.990-0.110 (-1.80%)
As of 11:59AM HKT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/4/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
72.61B68.32B81.06B91.93B97.85B
Enterprise Value
59.90B55.80B66.70B77.42B83.61B
Trailing P/E
10.9010.4612.2814.6615.87
Forward P/E
10.359.7311.7412.5612.99
PEG Ratio (5 yr expected)
7.90N/A2.532.712.29
Price/Sales (ttm)
2.132.032.412.722.95
Price/Book (mrq)
2.102.002.482.873.12
Enterprise Value/Revenue
1.917.178.319.6111.24
Enterprise Value/EBITDA
7.8628.8534.9843.3641.91

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3-30.37%
S&P500 52-Week Change 326.89%
52 Week High 38.890
52 Week Low 35.200
50-Day Moving Average 36.364
200-Day Moving Average 36.353

Share Statistics

Avg Vol (3 month) 337.78M
Avg Vol (10 day) 331.77M
Shares Outstanding 511.9B
Implied Shares Outstanding 611.94B
Float 88.29B
% Held by Insiders 129.67%
% Held by Institutions 131.15%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.28
Forward Annual Dividend Yield 44.59%
Trailing Annual Dividend Rate 30.23
Trailing Annual Dividend Yield 33.70%
5 Year Average Dividend Yield 42.03
Payout Ratio 444.59%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 07, 2023
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 19.54%
Operating Margin (ttm)22.23%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)31.31B
Revenue Per Share (ttm)2.63
Quarterly Revenue Growth (yoy)-1.30%
Gross Profit (ttm)N/A
EBITDA 7.76B
Net Income Avi to Common (ttm)6.12B
Diluted EPS (ttm)0.560
Quarterly Earnings Growth (yoy)1.70%

Balance Sheet

Total Cash (mrq)12.75B
Total Cash Per Share (mrq)1.08
Total Debt (mrq)415.26M
Total Debt/Equity (mrq)1.24%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)2.68

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A